Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × Burkitt Lymphoma × Clear all

NCT04034446 2025-06-03

CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase EARLY_PHASE1 Terminated

Burkitt Lymphoma, Recurrence

NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

Phase EARLY_PHASE1 Terminated

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell